Apolipoprotein H, a new mediator in the inflammatory changes ensuing in jeopardised human myocardium

نویسندگان

  • H W M Niessen
  • W K Lagrand
  • H J A M Rensink
  • Ch J L M Meijer
  • L Aarden
  • C E Hack
چکیده

Aim—To investigate the presence of membrane “flip flop” in ischaemic human myocardium, we assessed depositions of apolipoprotein H (apoH; â2-glycoprotein 1) in ischaemic myocardium. Serum protein apoH can bind to negatively charged phospholipids and can also inhibit blood coagulation in vitro. We hypothesised that, because of its aYnity for phosphatidyl serine, apoH might bind to “flip flopped” cells and would therefore be useful as a marker for membrane flip flop in vivo. Methods—Myocardial tissue specimens were obtained from patients who had died within 14 days of acute myocardial infarction. Results—Immunohistochemical analysis of these specimens revealed that apoH was selectively deposited in infarcted areas of human myocardium of at least one day’s duration. Depositions of apoH were not found in non-ischaemic myocardial tissue samples obtained from patients who died from other (extracardial) causes. In vitro experiments with the human leukaemia T cell line Jurkat, subjected to apoptosis by etoposide, showed that apoH was bound to the membrane of apoptotic cells. However, these experiments also indicated that flip flop itself is not suYcient for apoH binding. In addition, Jurkat cells that bound apoH were positive for activated complement complexes, as was also found in the human heart. Conclusions—These results suggest that apoH is involved in the inflammatory processes that occur in ischaemic myocardium. (J Clin Pathol 2000;53:863–867)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Apolipoprotein H, a new mediator in the inflammatory changes ensuring in jeopardised human myocardium.

AIM To investigate the presence of membrane "flip flop" in ischaemic human myocardium, we assessed depositions of apolipoprotein H (apoH; beta 2-glycoprotein 1) in ischaemic myocardium. Serum protein apoH can bind to negatively charged phospholipids and can also inhibit blood coagulation in vitro. We hypothesised that, because of its affinity for phosphatidyl serine, apoH might bind to "flip fl...

متن کامل

Dual-phase multi-detector computed tomography assesses jeopardised and infarcted myocardium subtending infarct-related artery early after acute myocardial infarction.

OBJECTIVES To investigate dual-phase multi-detector computed tomography (MDCT) for assessing extent and severity of jeopardised and infarcted myocardium subtended by infarct-related artery (IRA), and its indication for revascularisation after acute myocardial infarction (AMI). Designs, setting and PATIENTS Prospective, single-centre study included 107 patients with uncomplicated post-AMI 3-7 ...

متن کامل

IgM colocalises with complement and C reactive protein in infarcted human myocardium.

AIMS Reperfusion of ischaemic myocardium after acute myocardial infarction (AMI) can induce ischaemia/reperfusion (I/R) injury, as a result of local activation of the complement system. C reactive protein (CRP) is involved in this activation. This study analysed the potential role of IgM in complement activation in the infarcted human myocardium. METHODS Immunochemical analysis was carried ou...

متن کامل

Plasma Apolipoprotein-M (ApoM) Response to a Circuit Resistance Training Program

Apolipoprotein M (Apo-M) is a human novel protein of apolipoprotein classes and highly expressed in liver and kidney tissues. ApoM is mainly associated with high-density lipoprotein (HDL), and act as a chaperone for sphingosine-1-phosphate (S1P), promotes mobilization of cellular cholesterol, formation of larger-size of pre β-HDL, and a new biomarker in sepsis. The level of apoM in plasma/s...

متن کامل

O 2: Anti-Inflammatory Approach to Epilepsy Treatment

Epilepsy is one of the most common neurologic diseases around the world and more significantly in Iran (0.4-1 % worldwide and 5% in Iran). Almost one-third of these patients suffer from treatment-resistant epilepsy, which reduces their quality of life by recurring epileptic onsets. There are different approaches for the treatment of both treatment-resistant and treatment-nonresistant epilepsy, ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2000